184 related articles for article (PubMed ID: 31725060)
21. HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods.
Matthews LT; Ribaudo HB; Kaida A; Bennett K; Musinguzi N; Siedner MJ; Kabakyenga J; Hunt PW; Martin JN; Boum Y; Haberer JE; Bangsberg DR
J Acquir Immune Defic Syndr; 2016 Apr; 71(4):399-406. PubMed ID: 26495883
[TBL] [Abstract][Full Text] [Related]
22. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
[TBL] [Abstract][Full Text] [Related]
23. HIV Care Continuum among Postpartum Women Living with HIV in Atlanta.
Meade CM; Badell M; Hackett S; Mehta CC; Haddad LB; Camacho-Gonzalez A; Ford J; Holstad MM; Armstrong WS; Sheth AN
Infect Dis Obstet Gynecol; 2019; 2019():8161495. PubMed ID: 30894788
[TBL] [Abstract][Full Text] [Related]
24. Population-level risk factors for vertical transmission of HIV in the national prevention of mother-to-child transmission programme in South Africa: An ecological analysis.
Moyo F; Haeri Mazanderani A; Sherman GG; Kufa T
S Afr Med J; 2022 Mar; 112(3):219-226. PubMed ID: 35380525
[TBL] [Abstract][Full Text] [Related]
25. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S;
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184
[TBL] [Abstract][Full Text] [Related]
26. Self-Reported Long-Term Antiretroviral Adherence: A Longitudinal Study Among HIV Infected Pregnant Women in Mpumalanga, South Africa.
Ramlagan S; Rodriguez VJ; Peltzer K; Ruiter RAC; Jones DL; Sifunda S
AIDS Behav; 2019 Sep; 23(9):2576-2587. PubMed ID: 31228026
[TBL] [Abstract][Full Text] [Related]
27. More Frequent HIV Viral Load Testing With Point-Of-Care Tests Detects Elevated Viral Load Earlier in Postpartum HIV-Positive Women in a Randomized Controlled Trial in Two Clinics in Johannesburg, South Africa.
Fairlie L; Sawry S; Pals S; Sherman G; Williamson D; Le Roux J; Ngeno B; Berrie L; Diallo K; Cox MH; Mogashoa M; Chersich M; Modi S;
J Acquir Immune Defic Syndr; 2023 Dec; 94(5):412-420. PubMed ID: 37949444
[TBL] [Abstract][Full Text] [Related]
28. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
[TBL] [Abstract][Full Text] [Related]
29. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa.
Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N
PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865
[TBL] [Abstract][Full Text] [Related]
30. Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya.
Larson BA; Bii M; Halim N; Rohr JK; Sugut W; Sawe F
PLoS One; 2018; 13(8):e0200199. PubMed ID: 30096177
[TBL] [Abstract][Full Text] [Related]
31. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
[TBL] [Abstract][Full Text] [Related]
32. Maternal Motivation to Take Preventive Therapy in Antepartum and Postpartum Among HIV-Positive Pregnant Women in South Africa: A Choice Experiment.
Kim HY; Dowdy DW; Martinson NA; Kerrigan D; Tudor C; Golub J; Bridges JFP; Hanrahan CF
AIDS Behav; 2019 Jul; 23(7):1689-1697. PubMed ID: 30415430
[TBL] [Abstract][Full Text] [Related]
33. Effects of behavioural interventions on postpartum retention and adherence among women with HIV on lifelong ART: the results of a cluster randomized trial in Kenya (the MOTIVATE trial).
Abuogi LL; Onono M; Odeny TA; Owuor K; Helova A; Hampanda K; Odwar T; Onyango D; McClure LA; Bukusi EA; Turan JM
J Int AIDS Soc; 2022 Jan; 25(1):e25852. PubMed ID: 35041776
[TBL] [Abstract][Full Text] [Related]
34. A systematic review of health system barriers and enablers for antiretroviral therapy (ART) for HIV-infected pregnant and postpartum women.
Colvin CJ; Konopka S; Chalker JC; Jonas E; Albertini J; Amzel A; Fogg K
PLoS One; 2014; 9(10):e108150. PubMed ID: 25303241
[TBL] [Abstract][Full Text] [Related]
35. ART history prior to conception: trends and association with postpartum disengagement from HIV care in Khayelitsha, South Africa (2013-2019): a retrospective cohort study.
Phillips TK; Kassanjee R; Maxwell N; Anderson K; Johnson L; Moolla H; Myer L; Chi BH; Euvrard J; Boulle A; Davies MA; Cornell M; de Waal R
J Int AIDS Soc; 2024 Apr; 27(4):e26236. PubMed ID: 38566482
[TBL] [Abstract][Full Text] [Related]
36. The South African National HIV Pregnancy Cohort: evaluating continuity of care among women living with HIV.
Clouse K; Malope-Kgokong B; Bor J; Nattey C; Mudau M; Maskew M
BMC Public Health; 2020 Nov; 20(1):1662. PubMed ID: 33153468
[TBL] [Abstract][Full Text] [Related]
37. Conditional Cash Transfers to Increase Retention in PMTCT Care, Antiretroviral Adherence, and Postpartum Virological Suppression: A Randomized Controlled Trial.
Yotebieng M; Thirumurthy H; Moracco KE; Edmonds A; Tabala M; Kawende B; Wenzi LK; Okitolonda EW; Behets F
J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S124-9. PubMed ID: 27355499
[TBL] [Abstract][Full Text] [Related]
38. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
Myer L; Dunning L; Lesosky M; Hsiao NY; Phillips T; Petro G; Zerbe A; McIntyre JA; Abrams EJ
Clin Infect Dis; 2017 Feb; 64(4):422-427. PubMed ID: 27927852
[TBL] [Abstract][Full Text] [Related]
39. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women.
Hodgson I; Plummer ML; Konopka SN; Colvin CJ; Jonas E; Albertini J; Amzel A; Fogg KP
PLoS One; 2014; 9(11):e111421. PubMed ID: 25372479
[TBL] [Abstract][Full Text] [Related]
40. Increased Access to Antiretroviral Therapy Is Associated with Reduced Maternal Mortality in Johannesburg, South Africa: An Audit from 2003-2012.
Black V; Black AD; Rees HV; Guidozzi F; Scorgie F; Chersich MF
PLoS One; 2016; 11(12):e0168199. PubMed ID: 28033409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
